Multi-mission Ni-H2 battery cells for the 1990's

A sufficient production, test and operational database is now available to permit design technology optimization for the next decade. The evolved battery cell design features standardized technology intended to support multiple type missions (e.g., both GEO and LEO). Design analysis and validation test cells demonstrate that improved performance plus attractive specific-energy characteristics will be achieved

Corporate profitability and the dynamics of competition in emerging markets: a time series analysis

The paper presents time-series analyses of corporate profitability in seven leading developing countries (DCs) using the common methodology of the persistence of profitability (PP) studies and systematically compares the results with those for advanced countries (ACs). Surprisingly, both short- and long-term persistence of profitability for DCs are found to be lower than those for ACs. The paper concentrates on economic explanations for these findings. It also reports the results on the persistence of the two components of profitability - capital-output ratios and profit margins. These too raise important general issues of economic interpretation for PP studies which are outlinedCompetition, profitability, persistence, emerging markets

Multi-mission Ni-H2 battery cell for the 1990's

A sufficient production, test and operational database is now available to permit design technology optimization for the next decade. The evolved battery cell design features standardized technology intended to support multiple type missions (e.g., both GEO and LEO). Design analyses and validation test cells demonstrate improved performance plus attractive specific-energy characteristics will be achieved

Measuring Perceived Effects of Drinking an Extract of Basidiomycetes Agaricus Blazei Murill: A Survey of Japanese Consumers with Cancer

BACKGROUND. To survey cancer patients who consume an extract of the Basidiomycetes Agaricus blazei Murill mushroom (Sen-Sei-Ro) to measure their self-assessment of its effects and to develop an instrument for use in future randomized trials. METHODS. We designed, translated and mailed a survey to 2,346 Japanese consumers of Sen-Sei-Ro self-designated as cancer patients. The survey assessed consumer demographics, cancer history, Sen-Sei-Ro consumption, and its perceived effects. We performed exploratory psychometric analyses to identify distinct, multi-item scales that could summarize perceptions of effects. RESULTS. We received completed questionnaires from 782 (33%) of the sampled Sen-Sei-Ro consumers with a cancer history. Respondents represented a broad range of cancer patients familiar with Sen-Sei-Ro. Nearly all had begun consumption after their cancer diagnosis. These consumers expressed consistently positive views, though not extremely so, with more benefit reported for more abstract benefits such as emotional and physical well-being than relief of specific symptoms. We identified two conceptually and empirically distinct and internally consistent summary scales measuring Sen-Sei-Ro consumers' perceptions of its effects, Relief of Symptoms and Functional Well-being (Cronbach's alpha: Relief of Symptoms, α = .74; Functional Well-Being, α = .91). CONCLUSION. Respondents to our survey of Sen-Sei-Ro consumers with cancer reported favorable perceived effects from its use. Our instrument, when further validated, may be a useful outcome in trials assessing this and other complementary and alternative medicine (CAM) substances in cancer patients.Kyowa-S.S.I., Tokyo, Japa